Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to
improve the quality of life of people with hearing loss, today
reported its financial results for the first quarter ended March
31, 2021.
Christian Gormsen, President and CEO, said, “We started 2021
with a great first quarter, as our digital and offline marketing
programs continued to drive demand across multiple customer types,
including both cash pay and insurance customers producing 74%
year-over-year growth. Our first quarter growth was particularly
impressive given we did not have a new product launch or related
sales to repeat customers compared to the first quarter of 2020.
Our mix shift towards insurance customers also resulted in a lower
return accrual rate of 23.2%, which combined with higher average
selling prices, drove non-GAAP gross margin to 72.2%. Our strong
start to the year gives us increased confidence in our ability to
deliver our full year revenue and gross margin guidance, while
driving innovation across our value chain.”
Mr. Gormsen continued, “It is becoming more evident that
telecare is here to stay, not just in hearing but across
healthcare. As a pioneer in bringing a vertically integrated
telecare experience to hearing care, we believe we are well
positioned to lead the disruption of this large and underpenetrated
market as more consumers realize there is simply a better, more
efficient way to solve for hearing loss.”
First Quarter 2021 Financial ResultsNet revenue
was $22.0 million for the first quarter of 2021, compared to $12.7
million for the first quarter of 2020. The increase was driven by
an increase in gross systems shipped and a decrease in the sales
return accrual rate.
Gross profit for the first quarter of 2021 was $15.8 million
compared to $8.0 million for the first quarter of 2020. Gross
margin increased to 71.4% for the first quarter of 2021, compared
with 63.2% for the first quarter of 2020. The increase was
primarily due to a decrease in sales returns as a percentage of
gross systems shipped, higher average selling prices, and lower
cost of goods sold.
Total operating expenses were $29.1 million or 132.1% of net
revenues, for the first quarter of 2021, compared with $19.7
million or 155.9% of net revenues, for the first quarter of 2020.
The increase was primarily due to higher sales and marketing
investments related to media investments, personnel investments to
scale the organization for growth, stock-based compensation and
expenses related to being a public company.
Sales and marketing expenses were $16.9 million or 76.4% of net
revenues, for the first quarter of 2021, compared with $10.9
million or 85.7% of net revenues, for the first quarter of
2020.
Research and development expenses were $4.8 million or 21.7% of
net revenues, for the first quarter of 2021, compared with $2.8
million or 22.2% of net revenues, for the first quarter of
2020.
General and administrative expenses were $7.5 million or 34.0%
of net revenues for the first quarter of 2021, compared with $6.1
million or 48.0% of net revenues, for the first quarter of
2020.
Excluding stock-based compensation expense, non-GAAP operating
expenses were $24.2 million, including research and development
expenses of $3.7 million, sales and marketing expenses of $15.0
million, and general and administrative expenses of $5.5 million.
Please refer to the section below titled “Use of Non-GAAP Financial
Measures” and the non-GAAP reconciliation tables at the end of this
press release.
Net loss attributable to common stockholders for the first
quarter of 2021 was ($13.6) million, or ($0.36) per share, compared
to a net loss of ($11.7) million, or ($43.76) per share, for the
first quarter of 2020. Excluding stock-based compensation expense,
non-GAAP net loss attributable to common stockholders for the first
quarter of 2021 was ($8.5) million, or ($0.22) per share, compared
to a non-GAAP net loss of ($11.2) million, or ($41.81) per share
for the same period in 2020.
Cash and cash equivalents were $201.6 million as of March 31,
2021, compared to $212.2 million as of December 31, 2020.
Full Year 2021 Financial Guidance
- Increasing net revenue guidance from between $87 million and
$93 million to between $89 million and $93 million
- Reiterating GAAP gross margin guidance of between 68% and
71%
- Reiterating non-GAAP gross margin of between 70% and 72%
Conference Call and Web Cast InformationEargo
will host a conference call to discuss the first quarter financial
results after market close on Wednesday, May 12, 2021 at 2:00 p.m.
Pacific Time / 5:00 p.m. Eastern Time. The conference call can be
accessed live over the phone at (833) 649-1234 for U.S. callers or
(914) 987-7293 for international callers, using conference ID:
3971939. The live webinar can be accessed at ir.eargo.com.
About EargoEargo is a medical device company
dedicated to improving the quality of life of people with hearing
loss. Our innovative product and go-to-market approach address the
major challenges of traditional hearing aid adoption, including
social stigma, accessibility and cost. We believe our Eargo hearing
aids are the first and only virtually invisible, rechargeable,
completely-in-canal, FDA regulated, exempt Class I or Class II
devices for the treatment of hearing loss. Our differentiated,
consumer-first solution empowers consumers to take control of their
hearing. Consumers can purchase online or over the phone and get
personalized and convenient consultation and support from licensed
hearing professionals via phone, text, email or video chat. The
Eargo solution is offered to consumers at approximately half the
cost of competing hearing aids purchased through traditional
channels in the United States.
The company’s 4th generation product, the Eargo Neo HiFi, was
launched in January 2020 and features improved capabilities across
audio fidelity and bandwidth. The Eargo Neo HiFi is available for
purchase here.
Related Linkshttp://eargo.com
Forward-Looking StatementsThis press release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. All statements
other than statements of historical fact contained in this press
release are forward-looking statements, including statements
regarding our full year 2021 financial guidance, our ability to
deliver on that guidance while driving innovation, the future of
telecare and our position as a leader in market disruption.
Forward-looking statements are not guarantees of future performance
and are subject to risks, uncertainties and assumptions that could
cause actual results and events to differ materially from those
anticipated, including, but not limited to, risks, uncertainties
and assumptions related to: our expectations concerning additional
orders by existing customers; our expectations regarding the
potential market size and size of the potential consumer
populations for our products and any future products, including our
ability to maintain or increase insurance coverage of Eargo hearing
aids; our ability to release new hearing aids and the anticipated
features of any such hearing aids; developments and projections
relating to our competitors and our industry, including competing
products; our ability to maintain our competitive technological
advantages against new entrants in our industry; the pricing of our
hearing aids; our expectations regarding the ability to make
certain claims related to the performance of our hearing aids
relative to competitive products; our expectations with regard to
changes in the regulatory landscape for hearing aid devices,
including the implementation of the pending over-the-counter
hearing aid pathway regulatory framework; and our estimates
regarding the COVID-19 pandemic, including but not limited to, its
duration and its impact on our business and results of operations.
These and other risks are described in greater detail under the
section titled “Risk Factors” contained in Eargo’s Annual Report on
Form 10-K and Quarterly Reports on Form 10-Q and the company’s
other filings with the SEC. Any forward-looking statements in this
press release are made pursuant to the Private Securities
Litigation Reform Act of 1995, as amended, are based on current
expectations, forecasts and assumptions, and speak only as of the
date of this press release. Except as required by law, the company
undertakes no obligation to publicly update any forward-looking
statements, whether as a result of new information, future events
or otherwise.
Use of Non-GAAP Financial MeasuresThe company
may report non-GAAP results for gross profit/loss, gross margin,
operating expenses, operating margins, net income/loss, and basic
and diluted net income/loss per share in addition to, and not as a
substitute for, or superior to, financial measures calculated in
accordance with GAAP. The company’s financial measures under GAAP
include charges such as stock-based compensation, as listed in the
itemized reconciliations between GAAP and non-GAAP financial
measures included in this press release. Management has excluded
the effects of this item in non-GAAP measures to assist investors
in analyzing and assessing past and future operating performance.
The company encourages investors to carefully consider its results
under GAAP, as well as its supplemental non-GAAP information and
the reconciliation between these presentations, to more fully
understand its business.
Investor ContactNick LaudicoVice President of Investor
Relationsir@eargo.com
Media ContactBrad Sheetseargo@edelman.com
|
|
Eargo, Inc.Consolidated Balance
Sheets
(Unaudited)(In thousands,
except share and per share amounts) |
|
|
|
March 31, |
|
December 31, |
|
|
|
2021 |
|
|
|
2020 |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
201,624 |
|
|
$ |
212,185 |
|
Accounts receivable, net |
|
|
5,339 |
|
|
|
3,793 |
|
Inventories |
|
|
2,463 |
|
|
|
2,739 |
|
Prepaid expenses and other current assets |
|
|
3,175 |
|
|
|
3,740 |
|
Total current assets |
|
|
212,601 |
|
|
|
222,457 |
|
Operating lease right-of-use assets |
|
|
1,218 |
|
|
|
1,079 |
|
Property and equipment, net |
|
|
8,924 |
|
|
|
8,034 |
|
Other assets |
|
|
1,086 |
|
|
|
1,062 |
|
Total assets |
|
$ |
223,829 |
|
|
$ |
232,632 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
6,604 |
|
|
$ |
6,020 |
|
Accrued expenses |
|
|
10,992 |
|
|
|
13,909 |
|
Other current liabilities |
|
|
3,950 |
|
|
|
2,448 |
|
Deferred revenue, current portion |
|
|
173 |
|
|
|
311 |
|
Lease liability, current portion |
|
|
1,050 |
|
|
|
1,030 |
|
Total current liabilities |
|
|
22,769 |
|
|
|
23,718 |
|
Lease liability, noncurrent portion |
|
|
263 |
|
|
|
166 |
|
Long-term debt, noncurrent portion |
|
|
14,940 |
|
|
|
14,837 |
|
Total liabilities |
|
|
37,972 |
|
|
|
38,721 |
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
Preferred stock, $0.0001 par value per share; 5,000,000 shares
authorized |
|
|
|
|
|
|
|
|
as of March 31, 2021 and December 31, 2020, respectively; zero
shares issued and outstanding as of March 31, 2021 and December 31,
2020, respectively |
|
|
— |
|
|
|
— |
|
Common stock; $0.0001 par value; 110,000,000 shares authorized |
|
|
|
|
|
|
|
|
as of March 31, 2021 and December 31, 2020, respectively;
38,298,068 and 38,246,601 shares issued and outstanding as of March
31, 2021 and December 31, 2020, respectively |
|
|
4 |
|
|
|
4 |
|
Additional paid in capital |
|
|
398,532 |
|
|
|
392,965 |
|
Accumulated deficit |
|
|
(212,679 |
) |
|
|
(199,058 |
) |
Total stockholders’ equity |
|
|
185,857 |
|
|
|
193,911 |
|
Total liabilities and stockholders’ equity |
|
$ |
223,829 |
|
|
$ |
232,632 |
|
|
|
|
|
|
|
|
|
|
Eargo, Inc.Consolidated Statements of
Operations and Comprehensive
Loss(Unaudited)(In
thousands, except share and per share
amounts) |
|
|
|
Three months ended March 31, |
|
|
|
2021 |
|
|
|
2020 |
|
Revenue, net |
|
$ |
22,048 |
|
|
$ |
12,669 |
|
Cost of revenue |
|
|
6,297 |
|
|
|
4,656 |
|
Gross profit |
|
|
15,751 |
|
|
|
8,013 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
Research and development |
|
|
4,778 |
|
|
|
2,809 |
|
Sales and marketing |
|
|
16,855 |
|
|
|
10,859 |
|
General and administrative |
|
|
7,487 |
|
|
|
6,078 |
|
Total operating expenses |
|
|
29,120 |
|
|
|
19,746 |
|
Loss from operations |
|
|
(13,369 |
) |
|
|
(11,733 |
) |
Other income (expense), net: |
|
|
|
|
|
|
|
|
Interest income |
|
|
11 |
|
|
|
21 |
|
Interest expense |
|
|
(263 |
) |
|
|
(266 |
) |
Other income (expense), net |
|
|
— |
|
|
|
240 |
|
Total other income (expense), net |
|
|
(252 |
) |
|
|
(5 |
) |
Loss before income taxes |
|
|
(13,621 |
) |
|
|
(11,738 |
) |
Income tax provision |
|
|
— |
|
|
|
— |
|
Net loss and comprehensive loss |
|
$ |
(13,621 |
) |
|
$ |
(11,738 |
) |
Net income (loss) attributable to common stockholders, basic and
diluted |
|
$ |
(13,621 |
) |
|
$ |
(11,738 |
) |
Net income (loss) per share attributable to common stockholders,
basic and diluted |
|
$ |
(0.36 |
) |
|
$ |
(43.76 |
) |
Weighted-average shares used in computing net income (loss)
per |
|
|
|
|
|
|
|
|
share attributable to common stockholders, basic and diluted |
|
|
38,283,360 |
|
|
|
268,214 |
|
|
|
|
|
|
Eargo, Inc.Results of Operations –
Reconciliation between GAAP and
Non-GAAP(Unaudited)(In
thousands, except per share amounts) |
|
Reconciliation between GAAP and non-GAAP net loss per share
attributable to common stockholders: |
|
|
|
|
Three months ended March 31, |
|
|
2021 |
|
|
|
2020 |
|
GAAP net loss per share to common stockholders, basic and
diluted |
$ |
(0.36 |
) |
|
$ |
(43.76 |
) |
Stock-based compensation |
|
0.14 |
|
|
|
1.95 |
|
Non-GAAP net loss per share to common stockholders, basic and
diluted |
$ |
(0.22 |
) |
|
$ |
(41.81 |
) |
|
|
|
|
|
|
|
|
Reconciliation between GAAP and non-GAAP net loss
attributable to common stockholders: |
|
|
|
|
Three months ended March 31, |
|
|
2021 |
|
|
|
2020 |
|
GAAP net loss attributable to common stockholders, basic and
diluted |
$ |
(13,621 |
) |
|
$ |
(11,738 |
) |
Stock-based compensation |
|
5,131 |
|
|
|
525 |
|
Non-GAAP net loss attributable to common stockholders, basic and
diluted |
$ |
(8,490 |
) |
|
$ |
(11,213 |
) |
|
|
|
|
|
|
|
|
Reconciliation between GAAP and non-GAAP gross profit and
gross margin: |
|
|
|
|
Three months ended March 31, |
|
|
2021 |
|
|
|
2020 |
|
GAAP gross profit |
$ |
15,751 |
|
|
$ |
8,013 |
|
Stock-based compensation |
|
186 |
|
|
|
5 |
|
Non-GAAP gross profit |
$ |
15,937 |
|
|
$ |
8,018 |
|
|
|
|
|
GAAP gross margin |
|
71.4 |
% |
|
|
63.2 |
% |
Stock-based compensation |
|
0.8 |
% |
|
|
0.0 |
% |
Non-GAAP gross margin |
|
72.2 |
% |
|
|
63.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation between GAAP and non-GAAP operating expenses
and operating loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
2021 |
|
|
|
2020 |
|
GAAP research and development expense |
$ |
4,778 |
|
|
$ |
2,809 |
|
Stock-based compensation |
|
(1,067 |
) |
|
|
(164 |
) |
Non-GAAP research and development expense |
$ |
3,711 |
|
|
$ |
2,645 |
|
|
|
|
|
GAAP sales and marketing expense |
$ |
16,855 |
|
|
$ |
10,859 |
|
Stock-based compensation |
|
(1,856 |
) |
|
|
(123 |
) |
Non-GAAP sales and marketing expense |
$ |
14,999 |
|
|
$ |
10,736 |
|
|
|
|
|
GAAP general and administrative expense |
$ |
7,487 |
|
|
$ |
6,078 |
|
Stock-based compensation |
|
(2,022 |
) |
|
|
(233 |
) |
Non-GAAP general and administrative expense |
$ |
5,465 |
|
|
$ |
5,845 |
|
|
|
|
|
GAAP total operating expense |
$ |
29,120 |
|
|
$ |
19,746 |
|
Stock-based compensation |
|
(4,945 |
) |
|
|
(520 |
) |
Non-GAAP total operating expense |
$ |
24,175 |
|
|
$ |
19,226 |
|
|
|
|
|
GAAP operating loss |
$ |
(13,369 |
) |
|
$ |
(11,733 |
) |
Stock-based compensation |
|
5,131 |
|
|
|
525 |
|
Non-GAAP operating loss |
$ |
(8,238 |
) |
|
$ |
(11,208 |
) |
|
|
|
|
Reconciliation between GAAP and non-GAAP full year 2021
forecasted gross margin |
|
|
|
|
Low |
|
High |
Forecasted 2021 GAAP gross margin |
|
68% |
|
|
|
71% |
|
Estimated impact of stock-based compensation |
|
2.0% |
|
|
|
1.0% |
|
Forecasted 2021 non-GAAP gross margin |
|
70% |
|
|
|
72% |
|
Eargo (NASDAQ:EAR)
Historical Stock Chart
From Apr 2024 to May 2024
Eargo (NASDAQ:EAR)
Historical Stock Chart
From May 2023 to May 2024